Concepts (137)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Heart Function Tests | 1 | 2018 | 101 | 0.72 | Why? |
| Parasitic Diseases | 1 | 2018 | 84 | 0.70 | Why? |
| Sofosbuvir | 1 | 2018 | 518 | 0.52 | Why? |
| Ventricular Dysfunction, Left | 1 | 2018 | 993 | 0.40 | Why? |
| Ventricular Function, Left | 1 | 2018 | 1555 | 0.39 | Why? |
| Hepatitis C | 2 | 2018 | 1514 | 0.35 | Why? |
| Transients and Migrants | 1 | 2018 | 1468 | 0.31 | Why? |
| Postmortem Changes | 1 | 2021 | 133 | 0.21 | Why? |
| Drug Resistance, Multiple, Bacterial | 2 | 2019 | 1115 | 0.20 | Why? |
| Leishmania | 1 | 2018 | 28 | 0.18 | Why? |
| Leishmaniasis, Cutaneous | 1 | 2018 | 48 | 0.18 | Why? |
| Anemia, Hemolytic, Autoimmune | 1 | 2020 | 199 | 0.17 | Why? |
| Cephalosporins | 1 | 2019 | 250 | 0.17 | Why? |
| Lipocalin-2 | 1 | 2018 | 156 | 0.16 | Why? |
| Cadaver | 1 | 2021 | 626 | 0.16 | Why? |
| SARS Virus | 1 | 2020 | 13021 | 0.16 | Why? |
| Lymphocytes | 2 | 2021 | 3056 | 0.16 | Why? |
| Acinetobacter Infections | 1 | 2019 | 273 | 0.16 | Why? |
| Gram-Positive Bacteria | 1 | 2017 | 230 | 0.15 | Why? |
| Off-Label Use | 1 | 2020 | 553 | 0.15 | Why? |
| Cardiotoxicity | 1 | 2018 | 365 | 0.15 | Why? |
| Iron | 1 | 2021 | 619 | 0.14 | Why? |
| Klebsiella Infections | 1 | 2019 | 466 | 0.14 | Why? |
| Cannula | 1 | 2020 | 750 | 0.13 | Why? |
| Gram-Positive Bacterial Infections | 1 | 2017 | 323 | 0.13 | Why? |
| Gram-Negative Bacteria | 1 | 2017 | 473 | 0.12 | Why? |
| Gram-Negative Bacterial Infections | 1 | 2017 | 398 | 0.12 | Why? |
| Long-Term Care | 2 | 2021 | 2047 | 0.11 | Why? |
| Heparin, Low-Molecular-Weight | 1 | 2021 | 1731 | 0.11 | Why? |
| Autopsy | 1 | 2021 | 3495 | 0.10 | Why? |
| Uncertainty | 1 | 2020 | 1888 | 0.09 | Why? |
| Azithromycin | 2 | 2020 | 3943 | 0.09 | Why? |
| Thrombophilia | 1 | 2021 | 1935 | 0.09 | Why? |
| Monocytes | 1 | 2021 | 2978 | 0.09 | Why? |
| Lymphocyte Activation | 1 | 2018 | 2742 | 0.09 | Why? |
| Heparin | 1 | 2021 | 2600 | 0.09 | Why? |
| Oxygen Inhalation Therapy | 1 | 2020 | 3629 | 0.08 | Why? |
| Interleukin-6 | 2 | 2020 | 7522 | 0.07 | Why? |
| Fibrin Fibrinogen Degradation Products | 1 | 2021 | 5993 | 0.07 | Why? |
| Drug Therapy, Combination | 1 | 2018 | 7268 | 0.07 | Why? |
| Symptom Assessment | 1 | 2018 | 4967 | 0.07 | Why? |
| Angiotensin Receptor Antagonists | 1 | 2021 | 3892 | 0.07 | Why? |
| Italy | 5 | 2021 | 38444 | 0.07 | Why? |
| Echocardiography | 1 | 2018 | 3661 | 0.07 | Why? |
| ST Elevation Myocardial Infarction | 1 | 2020 | 3051 | 0.07 | Why? |
| C-Reactive Protein | 1 | 2020 | 7972 | 0.07 | Why? |
| Chronic Disease | 1 | 2018 | 5139 | 0.07 | Why? |
| Kidney | 1 | 2018 | 3648 | 0.06 | Why? |
| Anti-Bacterial Agents | 3 | 2020 | 10083 | 0.06 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2021 | 5277 | 0.06 | Why? |
| Longitudinal Studies | 1 | 2018 | 9893 | 0.06 | Why? |
| Aged | 10 | 2021 | 215776 | 0.06 | Why? |
| Asymptomatic Infections | 1 | 2020 | 7218 | 0.06 | Why? |
| Coombs Test | 1 | 2020 | 66 | 0.06 | Why? |
| Treatment Outcome | 4 | 2021 | 51732 | 0.05 | Why? |
| Diabetes Mellitus, Type 2 | 1 | 2021 | 6166 | 0.05 | Why? |
| Humans | 17 | 2021 | 930598 | 0.05 | Why? |
| Hydroxychloroquine | 2 | 2020 | 12447 | 0.05 | Why? |
| Hospital Mortality | 2 | 2021 | 22087 | 0.05 | Why? |
| Hypernatremia | 1 | 2020 | 182 | 0.05 | Why? |
| Azure Stains | 1 | 2018 | 3 | 0.05 | Why? |
| Anticoagulants | 1 | 2021 | 9563 | 0.05 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2020 | 9335 | 0.05 | Why? |
| Mass Screening | 1 | 2018 | 8005 | 0.05 | Why? |
| Respiratory Insufficiency | 1 | 2020 | 7301 | 0.04 | Why? |
| Antibodies, Protozoan | 1 | 2018 | 121 | 0.04 | Why? |
| Host-Pathogen Interactions | 1 | 2018 | 11041 | 0.04 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.04 | Why? |
| Male | 9 | 2021 | 367725 | 0.04 | Why? |
| Prednisolone | 1 | 2020 | 443 | 0.04 | Why? |
| Female | 9 | 2021 | 380317 | 0.04 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.04 | Why? |
| Prevalence | 1 | 2018 | 25773 | 0.04 | Why? |
| Pandemics | 3 | 2020 | 389249 | 0.04 | Why? |
| Acinetobacter baumannii | 1 | 2019 | 378 | 0.04 | Why? |
| Aged, 80 and over | 6 | 2021 | 88759 | 0.04 | Why? |
| Compassionate Use Trials | 1 | 2019 | 632 | 0.04 | Why? |
| Platelet Count | 1 | 2021 | 1381 | 0.03 | Why? |
| Middle Aged | 7 | 2021 | 270681 | 0.03 | Why? |
| Practice Guidelines as Topic | 1 | 2018 | 15421 | 0.03 | Why? |
| Klebsiella pneumoniae | 1 | 2019 | 658 | 0.03 | Why? |
| Prospective Studies | 1 | 2018 | 43301 | 0.03 | Why? |
| Immunophenotyping | 1 | 2018 | 1290 | 0.03 | Why? |
| Body Fluids | 1 | 2017 | 451 | 0.03 | Why? |
| Organ Specificity | 1 | 2017 | 1070 | 0.03 | Why? |
| Glomerular Filtration Rate | 1 | 2018 | 1262 | 0.03 | Why? |
| Young Adult | 2 | 2021 | 93724 | 0.03 | Why? |
| Africa | 1 | 2020 | 2986 | 0.03 | Why? |
| Leukocyte Count | 1 | 2021 | 3178 | 0.03 | Why? |
| Continuous Positive Airway Pressure | 1 | 2020 | 1187 | 0.03 | Why? |
| Microbial Sensitivity Tests | 1 | 2019 | 2886 | 0.03 | Why? |
| T-Lymphocyte Subsets | 1 | 2018 | 1387 | 0.03 | Why? |
| Platelet Aggregation Inhibitors | 1 | 2020 | 1671 | 0.03 | Why? |
| Hospital Units | 1 | 2017 | 1017 | 0.03 | Why? |
| Enzyme Inhibitors | 1 | 2020 | 1881 | 0.03 | Why? |
| Child | 1 | 2018 | 70012 | 0.02 | Why? |
| Pilot Projects | 1 | 2021 | 5182 | 0.02 | Why? |
| Antimicrobial Stewardship | 1 | 2017 | 931 | 0.02 | Why? |
| Hepacivirus | 1 | 2018 | 1509 | 0.02 | Why? |
| Lymphopenia | 1 | 2020 | 2669 | 0.02 | Why? |
| Retrospective Studies | 4 | 2021 | 105322 | 0.02 | Why? |
| Adolescent | 1 | 2018 | 86841 | 0.02 | Why? |
| Blood Coagulation | 1 | 2021 | 2768 | 0.02 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.02 | Why? |
| Survival Analysis | 1 | 2021 | 7592 | 0.02 | Why? |
| Noninvasive Ventilation | 1 | 2020 | 2329 | 0.02 | Why? |
| Electrocardiography | 1 | 2020 | 3957 | 0.02 | Why? |
| Lymphocyte Count | 1 | 2018 | 4758 | 0.02 | Why? |
| Genotype | 1 | 2018 | 4697 | 0.02 | Why? |
| Skin | 1 | 2018 | 2096 | 0.02 | Why? |
| Glucocorticoids | 1 | 2020 | 4431 | 0.02 | Why? |
| Community-Acquired Infections | 1 | 2017 | 2328 | 0.02 | Why? |
| Hospitals, University | 1 | 2017 | 4173 | 0.02 | Why? |
| Wounds and Injuries | 1 | 2017 | 1708 | 0.02 | Why? |
| Nursing Homes | 1 | 2020 | 4155 | 0.02 | Why? |
| Polymerase Chain Reaction | 1 | 2018 | 6740 | 0.02 | Why? |
| Risk Factors | 2 | 2021 | 71621 | 0.01 | Why? |
| Immunoglobulin M | 1 | 2018 | 9091 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2021 | 13720 | 0.01 | Why? |
| Hospitalization | 2 | 2021 | 54280 | 0.01 | Why? |
| Pneumonia | 1 | 2019 | 5652 | 0.01 | Why? |
| Tertiary Care Centers | 1 | 2017 | 8248 | 0.01 | Why? |
| Acute Kidney Injury | 1 | 2018 | 5762 | 0.01 | Why? |
| Biomarkers | 1 | 2021 | 23361 | 0.01 | Why? |
| Time Factors | 1 | 2021 | 31397 | 0.01 | Why? |
| Prognosis | 1 | 2021 | 32490 | 0.01 | Why? |
| Cohort Studies | 1 | 2020 | 36005 | 0.01 | Why? |
| Critical Illness | 1 | 2019 | 17281 | 0.01 | Why? |
| Cardiovascular Diseases | 1 | 2020 | 11497 | 0.01 | Why? |
| Influenza, Human | 1 | 2019 | 10779 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2018 | 21571 | 0.01 | Why? |
| China | 1 | 2020 | 50654 | 0.01 | Why? |
| Adult | 2 | 2021 | 244371 | 0.01 | Why? |
| RNA, Viral | 1 | 2018 | 32276 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2018 | 48226 | 0.01 | Why? |
| Infection Control | 1 | 2017 | 23131 | 0.01 | Why? |
| Antiviral Agents | 1 | 2018 | 41703 | 0.00 | Why? |
Mazzitelli's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(137)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(191)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_